KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$382M
This Quarter Return
+1.32%
1 Year Return
+13.86%
3 Year Return
+61.56%
5 Year Return
+124.1%
10 Year Return
+368.26%
AUM
$502M
AUM Growth
+$38.7M
(+8.3%)
Cap. Flow
+$35.2M
Cap. Flow
% of AUM
7%
Top 10 Holdings %
Top 10 Hldgs %
35.28%
Holding
145
New
16
Increased
39
Reduced
28
Closed
–
Top Buys
| 1 |
Unum
UNM
|
$13.7M |
| 2 |
Enovis
ENOV
|
$11.8M |
| 3 |
Aflac
AFL
|
$3.85M |
| 4 |
Qualcomm
QCOM
|
$1.91M |
| 5 |
3M
MMM
|
$1.53M |
Top Sells
| 1 |
Viatris
VTRS
|
$7.02M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
$2.72M |
| 3 |
Apple
AAPL
|
$1.27M |
| 4 |
Elevance Health
ELV
|
$938K |
| 5 |
Cisco
CSCO
|
$776K |
Sector Composition
| 1 | Healthcare | 22.41% |
| 2 | Technology | 17.31% |
| 3 | Financials | 15% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Amgen
AMGN
$153B
| $777K | 0.15% |
5,062
+4,900
| +3,025% | +$752K |
|
52
Pfizer
PFE
$141B
| $739K | 0.15% |
23,222
-1,091
| -4% | -$34.7K |
|
|
SI
53
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $738K | 0.15% |
7,330
| – | – |
|
54
AbbVie
ABBV
$374B
| $666K | 0.13% |
9,910
| – | – |
|
|
AGN
55
DELISTED
Allergan plc
AGN
| $660K | 0.13% |
2,174
-846
| -28% | -$257K |
|
56
Edwards Lifesciences
EW
$47.7B
| $655K | 0.13% |
27,600
| – | – |
|
57
Albemarle
ALB
$9.43B
| $643K | 0.13% |
11,640
| – | – |
|
58
Vodafone
VOD
$28.2B
| $608K | 0.12% |
16,682
| – | – |
|
59
Air Products & Chemicals
APD
$64.8B
| $602K | 0.12% |
+4,756
| New | +$602K |
|
60
Charles Schwab
SCHW
$175B
| $586K | 0.12% |
17,957
| – | – |
|
61
Smith & Nephew
SNN
$16.2B
| $570K | 0.11% |
16,800
+800
| +5% | +$27.1K |
|
62
Microsoft
MSFT
$3.76T
| $512K | 0.1% |
11,613
-50
| -0.4% | -$2.2K |
|
63
Abbott
ABT
$230B
| $479K | 0.1% |
9,760
-200
| -2% | -$9.82K |
|
64
Bristol-Myers Squibb
BMY
$96.7B
| $448K | 0.09% |
6,742
-25
| -0.4% | -$1.66K |
|
65
RTX Corp
RTX
$212B
| $438K | 0.09% |
6,281
+1,355
| +28% | +$94.5K |
|
66
Sanofi
SNY
$122B
| $393K | 0.08% |
7,925
+3,050
| +63% | +$151K |
|
67
PACCAR
PCAR
$50.5B
| $391K | 0.08% |
9,188
| – | – |
|
68
Avery Dennison
AVY
$13B
| $384K | 0.08% |
6,300
+650
| +12% | +$39.6K |
|
69
MetLife
MET
$53.6B
| $384K | 0.08% |
7,687
| – | – |
|
70
VeriSign
VRSN
$25.6B
| $380K | 0.08% |
6,153
| – | – |
|
71
BP
BP
$88.8B
| $366K | 0.07% |
10,874
-153
| -1% | -$5.15K |
|
72
Teva Pharmaceuticals
TEVA
$21.5B
| $361K | 0.07% |
6,100
| – | – |
|
|
SYT
73
DELISTED
Syngenta Ag
SYT
| $359K | 0.07% |
+4,400
| New | +$359K |
|
74
Oracle
ORCL
$628B
| $354K | 0.07% |
8,800
| – | – |
|
|
SWH
75
DELISTED
Stanley Black & Decker, Inc.
SWH
| $343K | 0.07% |
2,900
+2,200
| +314% | +$260K |
|